Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 018680209 approvals34 trials

SEOUL PHARMA CO.,LTD

Official website

Seoul Pharma, founded 1985 and KOSDAQ-listed 2000, makes ODF Vultis and diabetes drugs Januace, Janubex, Empavex.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Seoul Pharma was founded in December 1985 and listed on KOSDAQ in August 2000 as a pharmaceutical manufacturer. Its products include antibiotics Oclatin tablets, the hyperlipidemia drug Xlip sustained-release tablets, the orally disintegrating film (ODF) Vultis, and diabetes drugs Januace, Janubex, and Empavex tablets, made with its SmartFilm(R) ODF platform. It runs a single pharmaceutical manufacturing and sales segment, posted KRW 52,149 million in 2025 sales, led by Artimin, Panstar, and Seoul Famotidine tablets.

Products & technology

  • Oclatin TabletsBroad-spectrum antibiotic
  • Oclatin Dry SyrupBroad-spectrum antibiotic
  • Oclatin Duo Dry SyrupBroad-spectrum antibiotic
  • Sebron SyrupAcetylcysteine-based expectorant
  • Sebron-A SyrupAcetylcysteine-based expectorant
  • Xlip Sustained-Release TabletsHyperlipidemia treatment
  • VultisOrally disintegrating film (ODF), 140.45mg high-dose active ingredient
  • Januace TabletsType 2 diabetes treatment (DPP-4 salt-modified improved new drug)
  • Janubex TabletsType 2 diabetes treatment (DPP-4 salt-modified improved new drug)
  • Empavex TabletsType 2 diabetes treatment (SGLT2 inhibitor generic)
  • 알티민정
  • 팬스타정
  • 서울파모티딘정

Regulatory approvals

data.go.kr

209 Korean MFDS drug approvals · 1986–2026

  • MFDS drugCredipin Tab. 5/5mg2026-03-31
    Drug · Prescription · Approval202600911
  • MFDS drugCredipin Tab. 10/5mg2026-03-24
    Drug · Prescription · Approval202600827
  • MFDS drugCredipin Tab. 20/5mg2026-03-17
    Drug · Prescription · Approval202600773
  • MFDS drugValmote Tab. 0.5mg2025-09-26
    Drug · Prescription · Approval202502557
  • MFDS drugEMPABEX TAB. 12.5/500MG2025-07-08
    Drug · Prescription · Approval202501700
  • MFDS drugEMPABEX TAB. 12.5/850MG2025-07-08
    Drug · Prescription · Approval202501701
  • MFDS drugEMPABEX TAB. 12.5/1000MG2025-07-08
    Drug · Prescription · Approval202501702
  • MFDS drugEMPABEX TAB. 5/1000MG2025-07-04
    Drug · Prescription · Approval202501667
  • MFDS drugEMPABEX TAB. 5/850MG2025-07-04
    Drug · Prescription · Approval202501668
  • MFDS drugEMPABEX TAB. 5/500MG2025-07-04
    Drug · Prescription · Approval202501669
  • MFDS drugGraton Tab. 240mg2024-04-11
    Drug · OTC · Notification202400825
  • MFDS drugFabian D Tab.2023-12-27
    Drug · OTC · Notification202303447
Show 68 more
  • MFDS drugJANUBEX TAB. 50/1000MG2023-06-26
    Drug · Prescription · Approval202301949
  • MFDS drugJANUBEX TAB. 50/500MG2023-06-26
    Drug · Prescription · Approval202301950
  • MFDS drugJANUBEX TAB. 50/850MG2023-06-26
    Drug · Prescription · Approval202301951
  • MFDS drugJANU-S Tab. 50MG2023-06-22
    Drug · Prescription · Approval202301923
  • MFDS drugJANU-S Tab. 100MG2023-06-22
    Drug · Prescription · Approval202301924
  • MFDS drugSeoul Eperisone SR Tab.2021-12-08
    Drug · Prescription · Approval202107857
  • MFDS drugNeoduo Tab. 20/800mg2021-06-30
    Drug · Prescription · Approval202104972
  • MFDS drugRIVAVEL TABRevoked2021-05-07
    Drug · Prescription · Approval202103731
  • MFDS drugRIVAVEL TAB 15mgRevoked2021-05-07
    Drug · Prescription · Approval202103732
  • MFDS drugRIVAVEL TAB 10mgRevoked2021-05-07
    Drug · Prescription · Approval202103733
  • MFDS drugDUTOR TAB 10/10mg2021-02-18
    Drug · Prescription · Approval202101414
  • MFDS drugDUTOR TAB 10/20mg2021-02-18
    Drug · Prescription · Approval202101415
  • MFDS drugDUTOR TAB 10/40mgRevoked2021-02-18
    Drug · Prescription · Approval202101416
  • MFDS drugGraton Tab. 80mgRevoked2020-07-29
    Drug · OTC · Notification202005508
  • MFDS drugNeomac Tab. 75mg2020-05-21
    Drug · Prescription · Approval202003720
  • MFDS drugCellox Cap. 100mg2020-05-19
    Drug · Prescription · Approval202003628
  • MFDS drugSeoul Omega3 Soft Cap.2020-05-15
    Drug · Prescription · Approval202003513
  • MFDS drugCrestin Tab. 5mg2020-04-16
    Drug · Prescription · Approval202002683
  • MFDS drugT-Sartan Plus Tab. 40/12.5mg2019-12-05
    Drug · Prescription · Approval201908262
  • MFDS drugTencon Tab.Revoked2019-11-12
    Drug · Prescription · Approval201907873
  • MFDS drugEldoby Cap.2019-09-27
    Drug · OTC · Notification201906886
  • MFDS drugRabionedi Tab.Revoked2019-09-10
    Drug · Prescription · Approval201906384
  • MFDS drugPlavel Duo Cap.Revoked2019-06-04
    Drug · Prescription · Approval201903725
  • MFDS drugAhnpurabel Tab.Revoked2019-05-27
    Drug · Prescription · Approval201903438
  • MFDS drugApixthru Tab. 5mgRevoked2019-05-13
    Drug · Prescription · Approval201903074
  • MFDS drugApixthru Tab. 2.5mgRevoked2019-05-13
    Drug · Prescription · Approval201903075
  • MFDS drugSeoul Terbinafine HCl Tab.2019-05-10
    Drug · Prescription · Approval201903042
  • MFDS drugSeoul Cefixime Cap.2019-05-10
    Drug · Prescription · Approval201903043
  • MFDS drugSeoul Ticagrelor Tab. 90mgRevoked2019-05-08
    Drug · Prescription · Approval201902975
  • MFDS drugSeoul Febuxostat Tab. 80mg2019-05-07
    Drug · Prescription · Approval201902894
  • MFDS drugSeoul Febuxostat Tab. 40mg2019-05-07
    Drug · Prescription · Approval201902896
  • MFDS drugSeoul Raloxifene HCl Tab.Revoked2019-05-02
    Drug · Prescription · Approval201902848
  • MFDS drugSeoul Lansoprazole Cap. 30mgRevoked2019-04-30
    Drug · Prescription · Approval201902807
  • MFDS drugSeoul Lansoprazole Cap. 30mgRevoked2019-04-29
    Drug · Prescription · Approval201902717
  • MFDS drugSeoul Lansoprazole Cap. 30mg2019-04-24
    Drug · Prescription · Approval201902566
  • MFDS drugSeoul Lansoprazole Cap. 30mgRevoked2019-04-24
    Drug · Prescription · Approval201902567
  • MFDS drugS-Rokfen Tab.2019-04-23
    Drug · Prescription · Approval201902547
  • MFDS drugSeoul Pregabalin Cap. 75mgRevoked2019-04-16
    Drug · Prescription · Approval201902310
  • MFDS drugSeoul Pregabalin Cap. 150mgRevoked2019-04-16
    Drug · Prescription · Approval201902311
  • MFDS drugSeoul Naptopidil Tab. 75mgRevoked2019-04-09
    Drug · Prescription · Approval201902162
  • MFDS drugSeoul Naptopidil Tab. 50mgRevoked2019-04-09
    Drug · Prescription · Approval201902163
  • MFDS drugSeoul Naptopidil Tab. 25mgRevoked2019-04-09
    Drug · Prescription · Approval201902164
  • MFDS drugSeoul Ticagrelor Tab. 60mgRevoked2019-04-09
    Drug · Prescription · Approval201902166
  • MFDS drugVayduo Tab. 10/10mgRevoked2019-04-05
    Drug · Prescription · Approval201902086
  • MFDS drugVayduo Tab. 10/20mgRevoked2019-04-05
    Drug · Prescription · Approval201902087
  • MFDS drugSeoul Ezetimibe Tab.2019-04-04
    Drug · Prescription · Approval201902064
  • MFDS drugSeoul Gabapentin Cap. 100mg2019-03-28
    Drug · Prescription · Approval201901875
  • MFDS drugSeoul Gabapentin Cap. 300mg2019-03-28
    Drug · Prescription · Approval201901876
  • MFDS drugMacroxi Tab.2019-03-28
    Drug · Prescription · Approval201901877
  • MFDS drugSeoul Lafutidine Tab.2019-03-28
    Drug · Prescription · Approval201901881
  • MFDS drugSeoul Azelastine Hydrochloride Tab.2019-03-28
    Drug · Prescription · Approval201901882
  • MFDS drugSeoul Irsogladine Maleate Tab.Revoked2019-03-26
    Drug · Prescription · Approval201901788
  • MFDS drugArtpezil Tab. 5mg2019-03-19
    Drug · Prescription · Approval201901647
  • MFDS drugArtpezil Tab. 10mg2019-03-19
    Drug · Prescription · Approval201901648
  • MFDS drugSeoul Carvedilol Tab.Revoked2019-03-19
    Drug · Prescription · Approval201901657
  • MFDS drugTisartan Tab. 40mg2019-03-18
    Drug · Prescription · Approval201901614
  • MFDS drugTisartan Tab. 80mg2019-03-18
    Drug · Prescription · Approval201901615
  • MFDS drugDutadine Tab. 5/10mg2019-03-15
    Drug · Prescription · Approval201901592
  • MFDS drugDutadine Tab. 5/20mg2019-03-15
    Drug · Prescription · Approval201901593
  • MFDS drugSeoul Almagate Tab.2019-01-29
    Drug · OTC · Notification201900692
  • MFDS drugSeoul Aspirin Enteric Coated Tab.2019-01-15
    Drug · OTC · Notification201900178
  • MFDS drugGraton Tab.2018-05-28
    Drug · OTC · Notification201802183
  • MFDS drugUDcel Cap.2018-01-23
    Drug · Prescription · Approval201800307
  • MFDS drugR-Thimine Tab.2017-12-28
    Drug · Prescription · Approval201708609
  • MFDS drugPiro Vita Inj.(Ampule)2017-12-22
    Drug · Prescription · Notification201708548
  • MFDS drugSupofil Inj.2017-12-13
    Drug · Prescription · Notification201708354
  • MFDS drugAlcafone Soft Cap.2017-10-12
    Drug · Prescription · Approval201707391
  • MFDS drugTalita Tab.2017-07-13
    Drug · Prescription · Approval201705657

Showing the 80 most recent of 209 records.

Clinical trials

data.go.kr

34 MFDS clinical trial authorisations · 2012–2025 (Bioequivalence 31 · Phase 1 3)

  • Bioequivalence크레디핀정20/5밀리그램(로수바스타틴칼슘, 암로디핀베실산염)2025-03-04

    2 trial sites

  • Phase 1피타페노정2024-04-17

    1 trial site

  • Bioequivalence알러잘정(레보세티리진염산염)2024-03-21

    1 trial site

  • Bioequivalence엠파벡스정12.5/1000밀리그램(엠파글리플로진, 메트포르민염산염)2023-11-01

    1 trial site

  • Bioequivalence크레디핀정20/5밀리그램(로수바스타틴칼슘, 암로디핀베실산염)2023-10-17

    2 trial sites

  • Bioequivalence웰트민정(펜터민염산염)2023-05-08

    2 trial sites

  • Phase 1SPC-D-D012022-05-12

    1 trial site

  • Bioequivalence셀록스캡슐2021-12-31

    1 trial site

  • Phase 1SPC-D-S012021-12-08

    1 trial site

  • Bioequivalence네오메졸정40밀리그램2021-07-07

    1 trial site

  • Bioequivalence듀타딘정5/20밀리그램2021-06-23

    1 trial site

  • Bioequivalence서울티스타정80/5밀리그램2021-05-11

    2 trial sites

Show 22 more
  • Bioequivalence티살탄정80밀리그램(텔미사르탄)2021-05-07

    1 trial site

  • Bioequivalence클래리원정500밀리그램(클래리트로마이신)2021-04-07

    1 trial site

  • Bioequivalence서울가바펜틴캡슐300밀리그램2021-03-29

    1 trial site

  • Bioequivalence셀록스캡슐2021-03-29

    1 trial site

  • Bioequivalence팜시로빈정2021-03-02

    1 trial site

  • Bioequivalence트로셋정2021-02-05

    1 trial site

  • Bioequivalence알티민정(알티옥트산트로메타민염)2021-01-20

    1 trial site

  • Bioequivalence플라벨정(클로피도그렐황산염)2020-09-01

    1 trial site

  • Bioequivalence스키프라졸구강붕해필름10밀리그램(아리피프라졸)2018-09-27

    2 trial sites

  • Bioequivalence알카포네정(콜린알포세레이트)2018-03-16

    2 trial sites

  • Bioequivalence오디플루구강붕해필름75밀리그램(오셀타미비르인산염)2017-04-13

    2 trial sites

  • Bioequivalence오디플루과립(오셀타미비르인산염)2017-04-05

    2 trial sites

  • Bioequivalence오비케어구강붕해필름10밀리그램(솔리페나신숙신산염)2017-03-20

    2 trial sites

  • Bioequivalence레바스타정(레바미피드)2015-12-03

    2 trial sites

  • Bioequivalence티메롤이알서방정(아세트아미노펜)2015-11-25

    2 trial sites

  • Bioequivalence티로마정(티로프라미드염산염)2015-11-19

    2 trial sites

  • Bioequivalence모사정(모사프리드시트르산염이수화물)2015-10-23

    2 trial sites

  • Bioequivalence아토르정20밀리그램(아토르바스타틴칼슘삼수화물)의 생물학적동등성시험 계획서2014-12-12

    2 trial sites

  • Bioequivalence서울타다라필구강붕해필름5밀리그램2014-09-12

    2 trial sites

  • Bioequivalence서울타다라필구강붕해필름20밀리그램2014-03-19

    2 trial sites

  • Bioequivalence서울아리피프라졸구강붕해필름10밀리그램2013-04-04

    2 trial sites

  • Bioequivalence서울도네페질구강붕해필름10mg2012-08-23

    1 trial site

R&D and key agreements

Source: DART corporate disclosure

시타글립틴 · 제2형 당뇨병 · 시판 · Improved new drug; R&D started 2021; approved 2023-06-22

시타글립틴/메트포르민 · 제2형 당뇨병 · 시판 · Improved new drug; R&D started 2021; approved 2023-06-26

엠파글리플로진/메트포르민 · 제2형 당뇨병 · 시판 · Generic; R&D started 2023; approved 2025-07-08

로수바스타틴/암로디핀 · 고혈압/고지혈증 · 허가 진행 중 · Generic; R&D started 2023; approval in progress

에제티미브/피타바스타틴 · 고지혈증 · R&D · Generic; R&D started 2024

발사르탄/히드로클로로티아지드 · 고혈압 · R&D · Generic; R&D started 2025

Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

HL GENOMICS Co., Ltd.85
Kolmar BioTech, Inc.85

Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition